Department of Cardiology, German Paediatric Heart Centre, University of Bonn, Bonn, Germany.
Department of Cardiothoracic Surgery, German Paediatric Heart Centre, University of Bonn, Bonn, Germany.
Pacing Clin Electrophysiol. 2021 May;44(5):903-910. doi: 10.1111/pace.14213. Epub 2021 Mar 19.
Cardiac pacing can be challenging after a Fontan operation, and limited data exist regarding strategies to plan these epimyocardial systems while minimizing the number of surgical procedures.
A retrospective review of all our 47 patients (mean age 18 years, standard deviation 9 years) with a Fontan palliation who received an epimyocardial cardiac implantable electronic device (CIED) between 2002 and 2020 with regard to the stability of the epimyocardial lead parameters and the incidence of system revisions.
Over the last 18 years, 84 implantations or revisions of the epimyocardial CIED in 47 Fontan patients were performed. Mean age at time of the first implantation was 9.4 (range 0.28-29.3) years. Follow-up period ranges from 0.11 to 18.2 (mean 7.7, standard deviation 4.2) years. A total of 123 pacing leads were implanted of which 99 are still active. From 2010 triple lead cardiac resynchronization devices were used in 17 patients to better cope with lead problems. The initial pacing threshold of the leads inactivated during this study period proved significantly higher (mean 1.66 V) than in the "all leads" group (mean 1.27 V, p = .0005) or the group of the still active leads (mean 1.17 V, p = .00004).
When implanted with a low pacing threshold, the bipolar epimyocardial electrodes show stable and good long-term results in young patients with a Fontan circulation. Resynchronization pacing systems and the prospective implantation of reserve leads may help to reduce the rate of resternotomies and provide a flexible concept to deal with lead failure.
Fontan 手术后心脏起搏可能具有挑战性,并且关于规划这些心外膜系统的策略的数据有限,同时尽量减少手术次数。
回顾性分析了 2002 年至 2020 年间在我院接受心外膜心脏植入式电子设备(CIED)的 47 例 Fontan 姑息治疗患者的所有数据,评估心外膜导线参数的稳定性和系统修订的发生率。
在过去的 18 年中,对 47 例 Fontan 患者中的 84 例进行了心外膜 CIED 的植入或修订。首次植入时的平均年龄为 9.4 岁(范围 0.28-29.3 岁)。随访时间范围为 0.11 至 18.2 年(平均 7.7 年,标准差 4.2 年)。共植入 123 根起搏导线,其中 99 根仍在使用。从 2010 年开始,17 例患者使用了三腔心脏再同步治疗装置,以更好地应对导线问题。在本研究期间失活的导线的初始起搏阈值明显高于“所有导线”组(平均 1.27 V,p = 0.0005)或仍在使用的导线组(平均 1.17 V,p = 0.00004)。
在 Fontan 循环的年轻患者中,当植入具有低起搏阈值的双极心外膜电极时,其具有稳定且良好的长期效果。再同步起搏系统和前瞻性植入备用导线可能有助于降低胸骨切开术的发生率,并提供一种灵活的概念来处理导线故障。